Rheumatology Unit, Department of Internal Medicine, Azienda Ospedaliera ASMN, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy.
Clin Exp Rheumatol. 2014 May-Jun;32(3 Suppl 82):S106-11. Epub 2014 May 15.
Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are closely related disorders that affect people of middle age and older, and frequently occur together. With the widespread use of newer vascular imaging modalities, large-vessel involvement (LVI) has increasingly been recognised in patients with GCA and less often in those with PMR. LVI in GCA can result in complications such as aortic aneurysm and dissection, aortic arch syndrome, and limb arteries stenosis, while vascular complications in PMR are exceedingly rare. It is still controversial which patients should be investigated for LVI, and how LVI should be diagnosed, monitored and managed. In this review, we will try to address six important issues regarding LVI in GCA and PMR.
巨细胞动脉炎(GCA)和风湿性多肌痛(PMR)是两种密切相关的疾病,影响中老年人,且常同时发生。随着新型血管成像技术的广泛应用,越来越多的 GCA 患者出现大血管受累(LVI),而 PMR 患者则较少见。GCA 中的 LVI 可导致并发症,如主动脉瘤和夹层、主动脉弓综合征和肢体动脉狭窄,而 PMR 中的血管并发症极为罕见。目前仍存在争议,即哪些患者应进行 LVI 检查,以及如何诊断、监测和管理 LVI。在这篇综述中,我们将尝试解决 GCA 和 PMR 中 LVI 的六个重要问题。